Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-24 @ 11:44 PM
NCT ID:
NCT05395351
Eligibility Criteria:
Inclusion Criteria:
* Patient registered in the Chinese Stroke Centre Alliance (CSCA) platform from Aug 2015 to Jul 2019
* ≥18 years old
* Diagnosed as Acute Ischemic Stroke (AIS) at admission
* Arrived or admitted into hospital within 4.5 hours of symptom onset
* For patients in the iv rt-PA groups only: received IV rt-PA within 4.5 hours of symptom onset
Exclusion Criteria:
* Documented Intravenous Thrombolysis (IVT) absolute contraindication
* Key data missing (age, gender, baseline National Institutes of Health Stroke Scale \[NIHSS\], time of symptom onset, IVT treated or not, time of IV alteplase treatment)
* Received thrombolysis agents other than IV rt-PA (urokinase, tenecteplase, recombinant plasminogen activator, prourokinase, streptokinase)
* Received endovascular treatment
* Received IV rt-PA after 4.5 hours of symptom onset
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05395351
Study Brief:
Protocol Section:
NCT05395351